Wall Street Zen Upgrades Bioceres Crop Solutions (NASDAQ:BIOX) to “Hold”

Bioceres Crop Solutions (NASDAQ:BIOX) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday.

Separately, Oppenheimer decreased their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Bioceres Crop Solutions has an average rating of “Buy” and a consensus price target of $8.63.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX opened at $4.54 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.32 and a quick ratio of 0.96. The stock’s fifty day moving average price is $4.56 and its two-hundred day moving average price is $5.22. Bioceres Crop Solutions has a one year low of $3.51 and a one year high of $11.78. The firm has a market cap of $284.70 million, a price-to-earnings ratio of -32.43 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a negative return on equity of 2.36% and a negative net margin of 2.14%. The firm had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. On average, equities analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors have recently modified their holdings of BIOX. Fourth Sail Capital LP lifted its position in shares of Bioceres Crop Solutions by 25.1% during the 1st quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company’s stock valued at $21,125,000 after acquiring an additional 928,708 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Bioceres Crop Solutions by 135.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock valued at $4,574,000 after acquiring an additional 432,206 shares during the period. Long Focus Capital Management LLC lifted its position in shares of Bioceres Crop Solutions by 130.7% during the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after acquiring an additional 421,931 shares during the period. Allianz Asset Management GmbH lifted its position in shares of Bioceres Crop Solutions by 77.5% during the 1st quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company’s stock valued at $1,081,000 after acquiring an additional 103,337 shares during the period. Finally, Ballast Asset Management LP lifted its position in shares of Bioceres Crop Solutions by 23.5% during the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares during the period. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.